Sero-molecular Prevalence of Toxoplasmosis in Hemodialysis and Peritoneal Dialysis Patients in Markazi Province, Iran

Overview

Journal Trop Med Health

Date 2025 Jan 14

PMID 39810270

Authors

Hossein Sarmadian

Mana Shojapour

Fereshteh Chegeni

Mohammad Amin Tabatabaiefar

Farshid Haghverdi

Roham Sarmadian

Reza Ghasemikhah

Affiliations

Soon will be listed here.

Abstract

Background: Infectious diseases, particularly parasitic infections such as toxoplasmosis, contribute significantly to the morbidity and mortality of hemodialysis patients. Toxoplasma gondii infection poses serious risks, especially to immunocompromised individuals. This study aimed to assess the prevalence of latent toxoplasmosis in dialysis patients in Markazi Province, Iran.

Methods: A total of 181 patients (168 hemodialysis and 13 peritoneal dialysis) were included in this cross-sectional study. Blood samples were collected and tested for anti-Toxoplasma IgG and IgM antibodies using ELISA, while PCR was used to detect T. gondii DNA. Data were analyzed using SPSS, with P < 0.05 considered significant.

Results: Out of 181 patients, 123 (67.95%) were seropositive for IgG antibodies, with the highest prevalence in those aged over 60 years. No cases tested positive for IgM antibodies or T. gondii DNA. Age was significantly associated with higher seroprevalence (P < 0.05), but there were no significant differences regarding gender, dialysis type, or duration of dialysis.

Conclusion: The high prevalence of latent toxoplasmosis in dialysis patients underscores the need for regular screening to prevent serious complications. Given the limitations of serological tests, molecular diagnostics like PCR should be considered for better detection in immunocompromised patients.

References

Wang Z, Liu H, Ma Z, Ma H, Li Z, Yang Z . Infection in Immunocompromised Patients: A Systematic Review and Meta-Analysis. Front Microbiol. 2017; 8:389. PMC: 5343064. DOI: 10.3389/fmicb.2017.00389. View

Hill D, Dubey J . Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002; 8(10):634-40. DOI: 10.1046/j.1469-0691.2002.00485.x. View

Robert M, Brenier-Pinchart M, Garnaud C, Fricker-Hidalgo H, Pelloux H . Molecular diagnosis of toxoplasmosis: recent advances and a look to the future. Expert Rev Anti Infect Ther. 2021; 19(12):1529-1542. DOI: 10.1080/14787210.2021.1941867. View

Guo Z, Johnson A . Genetic characterization of Toxoplasma gondii strains by random amplified polymorphic DNA polymerase chain reaction. Parasitology. 1995; 111 ( Pt 2):127-32. DOI: 10.1017/s0031182000064866. View

Yarahmadi S, Saki J, Arjmand R, Shahbazian H . Toxoplasma gondii molecular detection and phylogenetic analysis in hemodialysis patients from Khuzestan, Southwest Iran. Trop Med Health. 2024; 52(1):19. PMC: 10863173. DOI: 10.1186/s41182-024-00585-5. View

Darde M, Bouteille B . Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol. 1992; 78(5):786-94. View

Rasti S, Hassanzadeh M, Soliemani A, Hooshyar H, Mousavi S, Nikoueinejad H . Serological and molecular survey of toxoplasmosis in renal transplant recipients and hemodialysis patients in Kashan and Qom regions, central Iran. Ren Fail. 2016; 38(6):970-3. DOI: 10.3109/0886022X.2016.1172940. View

Soltani S, Kahvaz M, Soltani S, Maghsoudi F, Foroutan M . Seroprevalence and associated risk factors of Toxoplasma gondii infection in patients undergoing hemodialysis and healthy group. BMC Res Notes. 2020; 13(1):551. PMC: 7720589. DOI: 10.1186/s13104-020-05396-5. View

Jones J, Kruszon-Moran D, Elder S, Rivera H, Press C, Montoya J . Infection in the United States, 2011-2014. Am J Trop Med Hyg. 2017; 98(2):551-557. PMC: 5929212. DOI: 10.4269/ajtmh.17-0677. View

10.

Kadkhodaei S, Jahromi Z, Taghipour A, Rezanezhad H, Solhjoo K . A Case-Control Seroprevalence Survey of Toxoplasmosis in Hemodialysis Patients and Healthy Subjects in Kazeroon and Jahrom Districts in Fars Province, Southern Iran. J Parasitol Res. 2023; 2023:8251462. PMC: 10560106. DOI: 10.1155/2023/8251462. View

11.

Saadat F, Mahmoudi M, Rajabi E, Atrkar Roshan Z, Majidi Shad B, Karanis P . Seroepidemiology and Associated Risk Factors of Toxoplasma gondii in Hemodialysis Patients. Acta Parasitol. 2020; 65(4):906-912. DOI: 10.1007/s11686-020-00238-7. View

12.

Pinto-Ferreira F, Caldart E, Pasquali A, Mitsuka-Bregano R, Freire R, Navarro I . Patterns of Transmission and Sources of Infection in Outbreaks of Human Toxoplasmosis. Emerg Infect Dis. 2019; 25(12):2177-2182. PMC: 6874273. DOI: 10.3201/eid2512.181565. View

13.

Dubey J . Advances in the life cycle of Toxoplasma gondii. Int J Parasitol. 1998; 28(7):1019-24. DOI: 10.1016/s0020-7519(98)00023-x. View

14.

Fadel E, El-Hady H, Ahmed A, Tolba M . Molecular diagnosis of human toxoplasmosis: the state of the art. J Parasit Dis. 2024; 48(2):201-216. PMC: 11147977. DOI: 10.1007/s12639-024-01667-1. View

15.

Halonen S, Weiss L . Toxoplasmosis. Handb Clin Neurol. 2013; 114:125-45. PMC: 4157368. DOI: 10.1016/B978-0-444-53490-3.00008-X. View

16.

Tenter A, Heckeroth A, Weiss L . Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30(12-13):1217-58. PMC: 3109627. DOI: 10.1016/s0020-7519(00)00124-7. View

17.

Foroutan M, Rostami A, Majidiani H, Riahi S, Khazaei S, Badri M . A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran. Epidemiol Health. 2018; 40:e2018016. PMC: 6060338. DOI: 10.4178/epih.e2018016. View

18.

Mousavi-Hasanzadeh M, Sarmadian H, Ghasemikhah R, Didehdar M, Shahdoust M, Maleki M . Evaluation of infection in western Iran: seroepidemiology and risk factors analysis. Trop Med Health. 2020; 48:35. PMC: 7236115. DOI: 10.1186/s41182-020-00222-x. View

19.

Seyyedpour S, Afshar P, Barzegarnejad A, Kalhori S, Agah R . Evaluation of Anti- Antibodies in Hemodialysis Patients with Chronic Kidney Disease in Sari, Iran. Nephrourol Mon. 2016; 8(6):e40182. PMC: 5120252. DOI: 10.5812/numonthly.40182. View

20.

Howe D, Honore S, Derouin F, Sibley L . Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol. 1997; 35(6):1411-4. PMC: 229759. DOI: 10.1128/jcm.35.6.1411-1414.1997. View